Christina Burke

Christina Burke

Auto-generated profile, based on publicly available information

Christina Burke

UCL Cancer Institute, London, United Kingdom

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
GKGerda Kildisiute
Gerda Kildisiute
WKWaleed Kholosy
Waleed Kholosy
MYMatthew D. Young
Matthew D. Young
KRKenny Roberts
Kenny Roberts
RERasa Elmentaite
Rasa Elmentaite
SBSam Behjati
Sam Behjati
Neuroblastoma is a childhood cancer that resembles developmental stages of the neural crest. It is not established what developmental processes neuroblastoma cancer cells represent. Here, we sought to reveal the phenotype of neuroblastoma cancer cells by comparing cancer (n= 19,723) with normal fetal adrenal single-cell transcriptomes (n= 57,972). Our principal finding was that the neuroblastoma cancer cell resembled fetal sympathoblasts, but no other fetal adrenal cell type. The sympathoblastic state was a universal feature of neuroblastoma cells, transcending cell cluster diversity, individual patients, and clinical phenotypes. We substantiated our findings in 650 neuroblastoma bulk transcriptomes and by integrating canonical features of the neuroblastoma genome with transcriptional signals. Overall, our observations indicate that a pan-neuroblastoma cancer cell state exists, which may be attractive for novel immunotherapeutic and targeted avenues.

23 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MYMatthew D. Young
Matthew D. Young
TMThomas J. Mitchell
Thomas J. Mitchell
LCLars Custers
Lars Custers
TMThanasis Margaritis
Thanasis Margaritis
FMFrancisco Morales-Rodriguez
Francisco Morales-Rodriguez
SBSam Behjati
Sam Behjati
Tumor cells may share some patterns of gene expression with their cell of origin, providing clues into the differentiation state and origin of cancer. Here, we study the differentiation state and cellular origin of 1300 childhood and adult kidney tumors. Using single cell mRNA reference maps of normal tissues, we quantify reference “cellular signals” in each tumor. Quantifying global differentiation, we find that childhood tumors exhibit fetal cellular signals, replacing the presumption of “fetalness” with a quantitative measure of immaturity. By contrast, in adult cancers our assessment refutes the suggestion of dedifferentiation towards a fetal state in most cases. We find an intimate connection between developmental mesenchymal populations and childhood renal tumors. We demonstrate the diagnostic potential of our approach with a case study of a cryptic renal tumor. Our findings provide a cellular definition of human renal tumors through an approach that is broadly applicable to human cancer.

14 July 2026 in Cancer Research
Verified
Journal Article
Open access
HWHolly J Whitfiled
Holly J Whitfiled
NANathaniel D. Anderson
Nathaniel D. Anderson
CBChristina Burke
Christina Burke
MKMarian J. Groot Koerkamp
Marian J. Groot Koerkamp
CPConor Parks
Conor Parks
SBSam Behjati
Sam Behjati
Somatic mutations often predict survival in childhood cancers, as exemplified in rhabdomyosarcoma (RMS), in which FOXO1 gene fusion status is a key prognostic feature. In this study, we examined single-cell transcriptomes and discovered that cancer cells of lethal disease converge on a common cell state with a shared transcriptional landscape, irrespective of fusion status. Nuclear transcriptomics, chromatin accessibility, spatial transcriptomics, perturbation studies, and previously published datasets validated the overarching high-risk cell state. The convergent cell state only partially overlapped with transcriptional effects of the FOXO1 fusion and unexpectedly exhibited neural features. Overall, these findings delineate a cell state of high-risk RMS cells that transcends conventional molecular and histologic boundaries, suggesting an overarching disease phenotype that could transform target discovery and inform clinical practice. Significance: Defining a convergent cell state of high-risk rhabdomyosarcoma that transcends existing histological and molecular features predictive of outcome provides biological insights into aggressive disease and uncovers potential biomarkers and therapeutic targets.

2 October 2026
Verified
Other
Open access
HWHolly J Whitfiled
Holly J Whitfiled
NANathaniel D. Anderson
Nathaniel D. Anderson
CBChristina Burke
Christina Burke
MKMarian J. Groot Koerkamp
Marian J. Groot Koerkamp
CPConor Parks
Conor Parks
SBSam Behjati
Sam Behjati
Multiomics profiling and clinical characterization of RMS across discovery and extension cohorts. A, A summary of previously published single-cell analyses of primary RMS. The current study (highlighted in blue) uniquely performed high-throughput single-cell transcriptomic profiling on fresh tissue, which preserves native gene expression states while minimizing artifacts caused by freezing. Sample numbers for our cohort only include samples that contain RMS cells. B, Heatmap depicts the application of sequencing assays across individual patients in the discovery cohort. Patients are grouped by clinical category: fusion-positive alveolar RMS (brown), fusion-negative with fatal outcome (red), and fusion-negative that have survived (purple). Each column represents an individual patient. The data indicates whether single-cell RNA-seq, WGS, and RNA-seq were performed. C, H&E-stained tumor sections from patients with fusion-negative RMS who died of their disease. These cases highlight histologic diversity and aggressive clinical behavior despite the absence of characteristic gene fusions.

2 October 2026
Verified
Other
Open access
HWHolly J Whitfiled
Holly J Whitfiled
NANathaniel D. Anderson
Nathaniel D. Anderson
CBChristina Burke
Christina Burke
MKMarian J. Groot Koerkamp
Marian J. Groot Koerkamp
CPConor Parks
Conor Parks
SBSam Behjati
Sam Behjati
Supplementary Table 9 from High-Risk Rhabdomyosarcomas Feature a Convergent Cell State

2 October 2026
Verified
Other
Open access
HWHolly J Whitfiled
Holly J Whitfiled
NANathaniel D. Anderson
Nathaniel D. Anderson
CBChristina Burke
Christina Burke
MKMarian J. Groot Koerkamp
Marian J. Groot Koerkamp
CPConor Parks
Conor Parks
SBSam Behjati
Sam Behjati
Supplementary Table 6 from High-Risk Rhabdomyosarcomas Feature a Convergent Cell State